Phase 3 PREPARE study: efficacy and safety of an RSV vaccine administered to pregnant women
ESPID Education. Muñoz F. 05/07/19; 263065 Disclosure(s)(s): Data shown are preliminary as provided by the study sponsor. Data is not final until published.
Dr. Flor Muñoz
Dr. Flor Muñoz
Members: Login with your ESPID members credentials.

Non-Members: Create a Free ESPID Guest account here and use the “Guest Access” button to login and access Regular content.
Discussion Forum (0)
Rate & Comment (0)
Code of conduct/disclaimer available in General Terms & Conditions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies